Stem Cell Therapeutics Announces Presentation by Dr. Joshua M. Hare on NTx-265(R) Animal Data After Post-Myocardial Infarction in the Heart

ORLANDO, Fla.--(BUSINESS WIRE)--Removing thrombus from coronary arteries with the Export Aspiration Catheter from Medtronic, Inc. (NYSE:MDT), before implanting a stent in patients suffering a specific kind of heart attack, “results in excellent clinical outcomes,” at one year, according to new data released today at the American College of Cardiology (ACC) meeting.

MORE ON THIS TOPIC